Population pharmacokinetics of cannabidiol and the impact of food and formulation on systemic exposure in children with drug-resistant developmental and epileptic encephalopathies
30/11/2024
Summary: Describing the pharmacokinetic profile of cannabidiol in 48 children with treatment-resistant epileptic encephalopathies, this study evaluated the effects of diet and formulation type on plasma concentrations across various clinical scenarios.
Back